Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mittie Doyle currently holds 210,530 shares of Avalo Therapeutics, Inc. (AVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mittie Doyle has been a net seller of AVTX stock. They have purchased $0 and sold $82.4K worth of shares.
Mittie Doyle's most recent insider trade was on Apr 6, 2026, when they sold 3,970 shares at $0.00 per share.
Mittie Doyle serves as Executive at Avalo Therapeutics, Inc. (AVTX). They have executed 8 insider transactions totaling $82.4K over their tenure at the company.
Mittie Doyle holds the position of Executive at Avalo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Mittie Doyle has shown a selling trading pattern, with $0 in total purchases and $82.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mittie Doyle was on Apr 6, 2026, when they sold $71.5K worth of AVTX shares. This transaction involved 3,970 shares at $18.01 per share.
Mittie Doyle currently owns 210,530 shares of Avalo Therapeutics, Inc. (AVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mittie Doyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mittie Doyle has 8 Form 4 filings on record as an insider at Avalo Therapeutics, Inc..
Set alerts for Mittie Doyle and 40,000+ other insiders.